• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Buyouts

Capiton buys majority stake in Axxence Group

  • Harriet Matthews
  • Harriet Matthews
  • 01 July 2021
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Capiton has acquired a majority stake in Germany-based natural aroma chemicals (NAC) producer Axxence Group in an MBO from the company's founder, Joost van Neck.

The company's management team has invested alongside Capiton as part of the succession solution.

Capiton intends to support the company's growth via investments in technology, as well as the expansion of the company's management capacity. Bolt-ons will also form part of the strategy, according to a statement.

Axxence Group

  • DEAL:

    Buyout

  • LOCATION:

    Emmerich

  • SECTOR:

    Speciality chemicals

  • FOUNDED:

    1986

  • TURNOVER:

    €31.2m (2019)

  • STAFF:

    120

The GP is deploying equity via Capiton VI, as well as a co-investment vehicle. Further funds are reserved for organic and inorganic growth.

Capiton VI is currently on the road with a target of €550m and a hard-cap of €600m. The fund writes equity tickets of €20-50m, focusing on DACH-region companies in the areas of medical technology, pharmaceuticals, industrial technology, and responsible consumption.

The fund has now made four platform deals and expects to make around 15 in total.

The vehicle is expected to hold a final close in summer 2021, as reported.

Company
Founded in 1986, Axxence produces NACs for flavouring and fragrance. According to its latest publicly available accounts, the business posted revenues of €31.2m in 2019, versus €30.4m in 2018. The company employs around 120 staff and is headquartered in Emmerich, with two manufacturing plants in Slovakia.

People
Capiton – Roumyana Schnettler (partner); Frank-Markus Winkler (managing partner); Thomas Brake (investment manager); Martin Gwashavanhu (investment analyst).
Axxence Group – Joost van Neck (founder).

Advisers
Equity – Deloitte (financial due diligence, tax); Clifford Chance (legal); Lupp & Partner (legal); EY (corporate finance); Roland Berger (commercial due diligence); Androschin & Partner (operational due diligence); Herter & Co (debt advisory); Ashurst (legal); Willis Towers Watson (insurance due diligence); ERM (environmental due diligence); Tauw (ESG due diligence).
Vendor – RSM, Karsten Ley (tax); Christian Weyers (financial due diligence); Heuking Kühn Lüer Wojtek, Martin Imhof, Sebastian Pollmeier (legal); Guido Hoffmann (legal); Moore/MTH, Pieter Steltenpool (tax).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Buyouts
  • DACH
  • Industrials
  • Germany
  • capiton AG

More on Buyouts

Clinical trials and biotechnology
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • Buyouts
  • 04 September 2023
EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
HR software solutions providers
Main Capital’s Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023
Ice cream
Exponent divests ‘significant' stake in Meadow to Canadian investor

Since 2018, GP has diversified food ingredients company's focus beyond commodity dairy

  • Exits
  • 22 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013